October 21, 2017 1:43 AM ET

Biotechnology

Company Overview of CohBar, Inc.

Key Executives for CohBar, Inc.

NameBoard RelationshipsTitleAge
Simon J. Allen MBA6 RelationshipsChief Executive Officer49
John M. Amatruda M.D., Ph.D.35 RelationshipsCo-Founder, Advisor & Consultant--
Nir Yacov Barzilai M.D.9 RelationshipsCo-Founder & Director61
Pinchas Cohen M.D., Dean59 RelationshipsCo-Founder & Director60
David A. Sinclair Ph.D.76 RelationshipsCo-Founder, Advisor & Consultant47
View More Key Executives

CohBar, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Albion J. Fitzgerald 9 RelationshipsCohBar, Inc.69
Pinchas Cohen M.D., Dean 59 RelationshipsCohBar, Inc.60
Nir Yacov Barzilai M.D. 9 RelationshipsCohBar, Inc.61
Jon L. Stern MBA 9 RelationshipsCohBar, Inc.62
Marc E. Goldberg J.D., MBA 33 RelationshipsBioVentures Investors, LLC60
View All Board Members

CohBar, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., MBAMarc E. Goldberg33 Relationships3 Executives
Advisory Board M.D.Amir Lerman48 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$268.1K
268.1K
390.5K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$268.1K
268.1K
17.9M
Compensation as of Fiscal Year 2016
CohBar, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Verseon Corporation Appoints Robert W. Karr as Non-Executive Class II Director
October 20, 2017 6:00 AM ET
Neurocrine Biosciences, Inc. Announces Management Changes
October 19, 2017 9:26 PM ET
AveXis, Inc. Announces Management Changes
October 19, 2017 8:58 PM ET
Peregrine Pharmaceuticals, Inc. and Avid Bioservices, Inc. Appoint Mark R. Bamforth as an Independent Member of the Board of Directors
October 19, 2017 12:05 PM ET
Cellect Biotechnology Ltd. Announces Executive Changes
October 19, 2017 11:05 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CohBar, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.